Yue Kin Man
Associate Professor
Department of Chinese Medicine
Institute for Advancing Translational Medicine in Bone and Joint Disease
China
Biography
"Academic qualifications: 1985 B. Sc Biochemistry & Medical Cell Biology (Honours), University of Liverpool, Liverpool, U.K. 1989 Ph.D. Biochemistry & Molecular Biology, University of Liverpool, Liverpool, U.K. 2006 B.CM. Chinese Medicine, Hong Kong Baptist University, Hong Kong. Previous academic positions held: 1985-1989 Research Assistant Department of Biochemistry, University of Liverpool, Liverpool, U.K. 1989-1991 Postdoctoral Research Associate Department of Genetics, University of Leicester, U.K. 1991-1995 Postdoctoral Research Fellow Cancer Research Campaign, University of Manchester, U.K. 1995-1998 Lecturer in Clinical Biochem Department of Clinical Biochemistry, Faculty of Medicine, the Queen’s University of Belfast, U.K. 1998-2003 Assistant Professor School of Chinese Medicine, Hong Kong Baptist University Present academic position: 2003- present 2012- present Associate Professor Associate Director School of Chinese Medicine, Hong Kong Baptist University Teaching and Research Division, School of Chinese Medicine, Hong Kong Baptist University"
Research Interest
"Molecular understandings in pathogenesis of different diabetic complications including diabetic retinopathy, diabetic nephropathy, diabetic cerebral vasculopathy and diabetic macrovasculopathy Correlation between diabetes mellitus and osteoporesis Effects of Chinese medicinal compounds in the treatment of diabetic complications"
Publications
-
Wong DPK, Chu MT, Hung VKL, Lee DKM, Cheng CHK, Yung KKL, Yue KKM (Corresponding Author). Modulation of endoplasmic reticulum chaperone GRP78 by high glucose in hippocampus of streptozotocin-induced diabetic mice and C6 astrocytic cells. Neurochem. Int. 2013, 63, 551-560
-
Guo B, Zhang B, Zheng L, Tang T, Liu J, Wu H, Yang Z, Peng S, He 5, Zhang H, Yue KKM, He F, Zhang L, Qin L, Bian Z, Tan W, Liang Z, Lu A, Zhang G. Therapeutic RNA interference targeting CKIP-1 with a cross-species sequence to stimulate bone formation. Bone 2014, 59, 76-88.
-
Chu JM, Lee DK2, Wong DP, Wong RN, Yung KK, Cheng CH, Yue KKM (Corresponding Author). Ginsenosides attenuate methylglyoxal-induced impairment of insulin signaling and subsequent apoptosis in primary astrocytes. Neuropharmacol. 2014, 85, 215-223.
